ICICI Prudential Quant Fund - Growth - Regular Plan

Other Plans and Options
  • 0.4 %Nav, as on 02-06-2023

  • Previous Nav

  • Net Change on 02-06-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by predominantly investing in equity andequity related instruments selected based on a quantitative model.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE 200 - TRI 3.34 8.63 12.56 25.54 12.97 11.08

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI Magnum Equity ESG Fund- REGULAR PLAN - Growth Jan 01, 1991 12.77 22.82 11.97 2.02 4,543.71
Tata Ethical Fund Regular Plan - Growth May 24, 1996 11.82 25.92 13.54 2.12 1,570.10
HDFC Housing Opportunities Fund - Growth Option Dec 06, 2017 18.82 26.90 8.77 2.27 1,108.40
Edelweiss Recently Listed IPO Fund - Regular Plan Growth Feb 22, 2018 3.53 24.05 12.62 2.27 872.15
Franklin India Opportunities Fund - Growth Feb 21, 2000 Unrated 24.63 28.86 12.18 2.45 681.73

Fund Holdings as on 30-April-2023

  • Infosys Ltd.

  • Tata Consultancy Services Ltd.

  • Ultratech Cement Ltd.

  • Sun Pharmaceutical Industries Ltd.

  • HDFC Ltd.

  • Muthoot Finance Ltd.

  • Marico Ltd.

  • HCL Technologies Ltd.

  • Bharti Airtel Ltd.

  • Britannia Industries Ltd.

  • ICICI Bank Ltd.

  • ITC Ltd.

  • Cash Margin - Derivatives

  • Glaxosmithkline Pharmaceuticals Ltd.

  • Axis Bank Ltd.

  • Shree Cements Ltd.

  • Abbott India Ltd.

  • Colgate - Palmolive (India) Ltd.

  • Coal India Ltd.

  • JSW Steel Ltd.

  • Petronet LNG Ltd.

  • Bajaj Finance Ltd.

  • TREPS

  • Ashok Leyland Ltd.

  • Deepak Nitrite Ltd.

  • HDFC Asset Management Company Ltd.

  • Dabur India Ltd.

  • Kotak Mahindra Bank Ltd.

  • Persistent Systems Ltd.

  • SBI Cards & Payment Services Ltd.

  • LIC Housing Finance Ltd.

  • Bandhan Bank Ltd.

  • Bata India Ltd.

  • Hindustan Petroleum Corporation Ltd.

  • Bharat Petroleum Corporation Ltd.

  • Coromandel International Ltd.

  • Page Industries Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Net Current Assets

  • Supreme Industries Ltd.

  • Tata Communications Ltd.

  • Steel Authority Of India Ltd.

View More

  • IT - Software

  • Pharmaceuticals & Drugs

  • Bank - Private

  • Cement & Construction Materials

  • Finance - NBFC

  • Consumer Food

  • Miscellaneous

  • Finance - Housing

  • Household & Personal Products

  • Telecommunication - Service Provider

  • Cigarettes/Tobacco

  • Refineries

  • Steel & Iron Products

  • Mining & Minerals

  • Industrial Gases & Fuels

  • Automobiles-Trucks/Lcv

  • Chemicals

  • Finance - Asset Management

  • Retailing

  • Fertilizers

  • Textile

  • Plastic Products

View More

  • Cash

  • Equity

View More

About ICICI Prudential Quant Fund

Scheme Analysis

ICICI Prudential Quant Fund is a Equity - Thematic Fund - Other fund and belongs to ICICI Prudential Mutual Fund. It was launched on 11-Dec-2020 and currently has an AUM of ₹55.55 crore. ICICI Prudential Quant Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE 200 - TRI as secondary index.

The NAV of ICICI Prudential Quant Fund ended up ₹0.06(0.4%)yesterday to ₹15.16.

Among its top 3 holdings the fund has exposure to Infosys Ltd., and

The ICICI Prudential Quant Fund is managed by Roshan Chutkey .

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100